Loading…
In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice
Background Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation...
Saved in:
Published in: | Transfusion (Philadelphia, Pa.) Pa.), 2021-03, Vol.61 (3), p.687-691 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293 |
---|---|
cites | cdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293 |
container_end_page | 691 |
container_issue | 3 |
container_start_page | 687 |
container_title | Transfusion (Philadelphia, Pa.) |
container_volume | 61 |
creator | Poston, Jacqueline N. Jash, Arijita Hannan, Lindsay M. Hay, Ariel M. Usaneerungrueng, Chomkan Howie, Heather L. Kapp, Linda M. Zimring, James C. |
description | Background
Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations.
Study Design and Methods
A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens.
Results
No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion.
Conclusions
These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation. |
doi_str_mv | 10.1111/trf.16224 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9157413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2501868305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</originalsourceid><addsrcrecordid>eNp1kUFLHDEUx0NR6qo99AvIgJf2MGtekslsLoIsagVBKPbgKcTZNxrJJNsk01Y_fbPuVqzguwRefvz5Pf6EfAY6hTJHOfZTkIyJD2QCDW9rplSzRSaUCqgBONshuyk9UEqZovCR7PAyUoCYkJsLX40ZY6jwzzKkMWKVQ2WcC8Zne4c-VctoB0zPOzsMo7dPJtvgV9zSmYwOc5Wj8akf02pvfTXYDvfJdm9cwk-bd4_8ODu9nn-rL6_OL-Ynl3UnBBc1g1s663pJJeNKti02SiDtGUMlhBKyZTMQ7YI2oGTXg1QLsWC84xJZy5EpvkeO17nL8XbARYe-yDi9sjbxUQdj9f8_3t7ru_BLK2haAbwEfNkExPBzxJT1YFOHzhmPYUyaiRaKh2CyoIdv0IcwRl_O06yhMJMzTptCfV1TXQwpRexfZIDqVWG6FKafCyvswWv7F_JfQwU4WgO_rcPH95P09fezdeRfin6fyQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2501868305</pqid></control><display><type>article</type><title>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</title><source>Wiley</source><creator>Poston, Jacqueline N. ; Jash, Arijita ; Hannan, Lindsay M. ; Hay, Ariel M. ; Usaneerungrueng, Chomkan ; Howie, Heather L. ; Kapp, Linda M. ; Zimring, James C.</creator><creatorcontrib>Poston, Jacqueline N. ; Jash, Arijita ; Hannan, Lindsay M. ; Hay, Ariel M. ; Usaneerungrueng, Chomkan ; Howie, Heather L. ; Kapp, Linda M. ; Zimring, James C.</creatorcontrib><description>Background
Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations.
Study Design and Methods
A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens.
Results
No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion.
Conclusions
These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.</description><identifier>ISSN: 0041-1132</identifier><identifier>ISSN: 1537-2995</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/trf.16224</identifier><identifier>PMID: 33336414</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Alloantibodies ; Alloantigens ; Animal models ; Animals ; Antibodies ; Antigens ; Blood platelets ; Blood Platelets - immunology ; Breeding ; Female ; Histocompatibility antigen HLA ; HLA Antigens - immunology ; Human populations ; Independent variables ; Intrauterine exposure ; Isoantibodies - blood ; Isoantibodies - immunology ; Isoantigens - blood ; Isoantigens - immunology ; Isoimmunization ; Leukocytes ; Major histocompatibility complex ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Platelet Transfusion - adverse effects ; Platelets ; Population studies ; Pregnancy ; Thermal resistance ; Thrombocytopenia ; Transfusion ; Transplantation</subject><ispartof>Transfusion (Philadelphia, Pa.), 2021-03, Vol.61 (3), p.687-691</ispartof><rights>2020 AABB</rights><rights>2020 AABB.</rights><rights>2021 AABB</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</citedby><cites>FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</cites><orcidid>0000-0003-2431-5106 ; 0000-0002-1063-4010</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33336414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poston, Jacqueline N.</creatorcontrib><creatorcontrib>Jash, Arijita</creatorcontrib><creatorcontrib>Hannan, Lindsay M.</creatorcontrib><creatorcontrib>Hay, Ariel M.</creatorcontrib><creatorcontrib>Usaneerungrueng, Chomkan</creatorcontrib><creatorcontrib>Howie, Heather L.</creatorcontrib><creatorcontrib>Kapp, Linda M.</creatorcontrib><creatorcontrib>Zimring, James C.</creatorcontrib><title>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>Background
Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations.
Study Design and Methods
A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens.
Results
No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion.
Conclusions
These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.</description><subject>Alloantibodies</subject><subject>Alloantigens</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Blood platelets</subject><subject>Blood Platelets - immunology</subject><subject>Breeding</subject><subject>Female</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA Antigens - immunology</subject><subject>Human populations</subject><subject>Independent variables</subject><subject>Intrauterine exposure</subject><subject>Isoantibodies - blood</subject><subject>Isoantibodies - immunology</subject><subject>Isoantigens - blood</subject><subject>Isoantigens - immunology</subject><subject>Isoimmunization</subject><subject>Leukocytes</subject><subject>Major histocompatibility complex</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Platelet Transfusion - adverse effects</subject><subject>Platelets</subject><subject>Population studies</subject><subject>Pregnancy</subject><subject>Thermal resistance</subject><subject>Thrombocytopenia</subject><subject>Transfusion</subject><subject>Transplantation</subject><issn>0041-1132</issn><issn>1537-2995</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kUFLHDEUx0NR6qo99AvIgJf2MGtekslsLoIsagVBKPbgKcTZNxrJJNsk01Y_fbPuVqzguwRefvz5Pf6EfAY6hTJHOfZTkIyJD2QCDW9rplSzRSaUCqgBONshuyk9UEqZovCR7PAyUoCYkJsLX40ZY6jwzzKkMWKVQ2WcC8Zne4c-VctoB0zPOzsMo7dPJtvgV9zSmYwOc5Wj8akf02pvfTXYDvfJdm9cwk-bd4_8ODu9nn-rL6_OL-Ynl3UnBBc1g1s663pJJeNKti02SiDtGUMlhBKyZTMQ7YI2oGTXg1QLsWC84xJZy5EpvkeO17nL8XbARYe-yDi9sjbxUQdj9f8_3t7ru_BLK2haAbwEfNkExPBzxJT1YFOHzhmPYUyaiRaKh2CyoIdv0IcwRl_O06yhMJMzTptCfV1TXQwpRexfZIDqVWG6FKafCyvswWv7F_JfQwU4WgO_rcPH95P09fezdeRfin6fyQ</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Poston, Jacqueline N.</creator><creator>Jash, Arijita</creator><creator>Hannan, Lindsay M.</creator><creator>Hay, Ariel M.</creator><creator>Usaneerungrueng, Chomkan</creator><creator>Howie, Heather L.</creator><creator>Kapp, Linda M.</creator><creator>Zimring, James C.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2431-5106</orcidid><orcidid>https://orcid.org/0000-0002-1063-4010</orcidid></search><sort><creationdate>202103</creationdate><title>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</title><author>Poston, Jacqueline N. ; Jash, Arijita ; Hannan, Lindsay M. ; Hay, Ariel M. ; Usaneerungrueng, Chomkan ; Howie, Heather L. ; Kapp, Linda M. ; Zimring, James C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alloantibodies</topic><topic>Alloantigens</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Blood platelets</topic><topic>Blood Platelets - immunology</topic><topic>Breeding</topic><topic>Female</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA Antigens - immunology</topic><topic>Human populations</topic><topic>Independent variables</topic><topic>Intrauterine exposure</topic><topic>Isoantibodies - blood</topic><topic>Isoantibodies - immunology</topic><topic>Isoantigens - blood</topic><topic>Isoantigens - immunology</topic><topic>Isoimmunization</topic><topic>Leukocytes</topic><topic>Major histocompatibility complex</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Platelet Transfusion - adverse effects</topic><topic>Platelets</topic><topic>Population studies</topic><topic>Pregnancy</topic><topic>Thermal resistance</topic><topic>Thrombocytopenia</topic><topic>Transfusion</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poston, Jacqueline N.</creatorcontrib><creatorcontrib>Jash, Arijita</creatorcontrib><creatorcontrib>Hannan, Lindsay M.</creatorcontrib><creatorcontrib>Hay, Ariel M.</creatorcontrib><creatorcontrib>Usaneerungrueng, Chomkan</creatorcontrib><creatorcontrib>Howie, Heather L.</creatorcontrib><creatorcontrib>Kapp, Linda M.</creatorcontrib><creatorcontrib>Zimring, James C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poston, Jacqueline N.</au><au>Jash, Arijita</au><au>Hannan, Lindsay M.</au><au>Hay, Ariel M.</au><au>Usaneerungrueng, Chomkan</au><au>Howie, Heather L.</au><au>Kapp, Linda M.</au><au>Zimring, James C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2021-03</date><risdate>2021</risdate><volume>61</volume><issue>3</issue><spage>687</spage><epage>691</epage><pages>687-691</pages><issn>0041-1132</issn><issn>1537-2995</issn><eissn>1537-2995</eissn><abstract>Background
Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations.
Study Design and Methods
A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens.
Results
No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion.
Conclusions
These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>33336414</pmid><doi>10.1111/trf.16224</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-2431-5106</orcidid><orcidid>https://orcid.org/0000-0002-1063-4010</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1132 |
ispartof | Transfusion (Philadelphia, Pa.), 2021-03, Vol.61 (3), p.687-691 |
issn | 0041-1132 1537-2995 1537-2995 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9157413 |
source | Wiley |
subjects | Alloantibodies Alloantigens Animal models Animals Antibodies Antigens Blood platelets Blood Platelets - immunology Breeding Female Histocompatibility antigen HLA HLA Antigens - immunology Human populations Independent variables Intrauterine exposure Isoantibodies - blood Isoantibodies - immunology Isoantigens - blood Isoantigens - immunology Isoimmunization Leukocytes Major histocompatibility complex Male Mice Mice, Inbred BALB C Mice, Inbred C57BL Platelet Transfusion - adverse effects Platelets Population studies Pregnancy Thermal resistance Thrombocytopenia Transfusion Transplantation |
title | In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A56%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20utero%20exposure%20to%20alloantigens%20primes%20alloimmunization%20to%20platelet%20transfusion%20in%20mice&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Poston,%20Jacqueline%20N.&rft.date=2021-03&rft.volume=61&rft.issue=3&rft.spage=687&rft.epage=691&rft.pages=687-691&rft.issn=0041-1132&rft.eissn=1537-2995&rft_id=info:doi/10.1111/trf.16224&rft_dat=%3Cproquest_pubme%3E2501868305%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2501868305&rft_id=info:pmid/33336414&rfr_iscdi=true |